RxNorm Semantic Concepts Index - 318
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "318".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 318 | ATP - Adenosine triphosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 318 | ATP - Adenosine triphosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 318 | ATP - Adenosine triphosphate | Designated preferred name (PT) | YES | |
| RxCUI: 318 | ATP - Adenosine triphosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 318 | ATP - Adenosine triphosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 318 | ATP - Adenosine triphosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 318 | ATP - Adenosine triphosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 31805 | nilutamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 31805 | nilutamide | Designated preferred name (PT) | YES | |
| RxCUI: 31805 | nilutamide | Full form of descriptor (FN) | YES | |
| RxCUI: 31805 | nilutamide | Designated preferred name (PT) | YES | |
| RxCUI: 31805 | nilutamide | Full form of descriptor (FN) | YES | |
| RxCUI: 318076 | calcium carbonate 500 MG (Ca 200 MG) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 318076 | calcium carbonate 500 MG (Ca 200 MG) Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318130 | Patch | Dose Form (DF) | NO | |
| RxCUI: 318132 | BOIL-EASE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 318146 | dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 318146 | dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 318146 | dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 318178 | dihydroergocornine 0.167 MG / dihydroergocristine 0.167 MG / dihydroergocryptine 0.167 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318179 | ergoloid mesylates 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 318179 | ergoloid mesylates 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 31819 | nitazoxanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 31819 | nitazoxanide | Designated preferred name (PT) | YES | |
| RxCUI: 31819 | nitazoxanide | Full form of descriptor (FN) | YES | |
| RxCUI: 31819 | nitazoxanide | Designated preferred name (PT) | YES | |
| RxCUI: 31819 | nitazoxanide | Full form of descriptor (FN) | YES | |
| RxCUI: 318202 | erythromycin 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 318202 | erythromycin 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 318202 | erythromycin 2 % Topical Solution | Designated preferred name (PT) | YES | |
| RxCUI: 318202 | erythromycin 2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 318202 | erythromycin 2 % Topical Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 318211 | Pot gluconate 6.66 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 318211 | Pot gluconate 6.66 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 318211 | Pot gluconate 6.66 MEQ Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318212 | sodium salicylate 650 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 318212 | sodium salicylate 650 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 318212 | sodium salicylate 650 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318212 | sodium salicylate 650 MG Delayed Release Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 318213 | sodium salicylate 325 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 318213 | sodium salicylate 325 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 318213 | sodium salicylate 325 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318213 | sodium salicylate 325 MG Delayed Release Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 318217 | sulfADIAZINE 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 318217 | sulfADIAZINE 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318217 | sulfADIAZINE 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 318218 | sulfadiazine 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 318218 | sulfadiazine 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 318218 | sulfadiazine 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318218 | sulfadiazine 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 318224 | linseed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 318224 | linseed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 318240 | testosterone 75 MG Subcutaneous Pellet Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 318240 | testosterone 75 MG Subcutaneous Pellet Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 318240 | testosterone 75 MG Subcutaneous Pellet Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 318241 | tetanus toxoid vaccine, inactivated 2 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318242 | tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318243 | tetanus toxoid vaccine, inactivated 0.5 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318248 | thiotepa 10.4 MG/ML Injectable Solution [Thioplex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 318248 | thiotepa 10.4 MG/ML Injectable Solution [Thioplex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 318248 | thiotepa 10.4 MG/ML Injectable Solution [Thioplex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 318270 | phenylephrine 1 MG/ML / pyrilamine 1.2 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 318271 | Hb 15(A13), Gly-arg | British preferred term (PTGB) | NO | |
| RxCUI: 318271 | Hb 15(A13), Gly-arg | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 318271 | Hb 15(A13), Gly-arg | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 318271 | Hb 15(A13), Gly-arg | Designated preferred name (PT) | NO | |
| RxCUI: 318271 | Hb 15(A13), Gly-arg | Full form of descriptor (FN) | NO | |
| RxCUI: 318272 | aspirin 81 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 318272 | aspirin 81 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 318272 | aspirin 81 MG Chewable Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 318272 | aspirin 81 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 318272 | aspirin 81 MG Chewable Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 31829 | Respiratory nitrate reductase | Designated preferred name (PT) | NO | |
| RxCUI: 31829 | Respiratory nitrate reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 31829 | Respiratory nitrate reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31830 | Nitrate reductase (reduced nicotinamide adenine dinucleotide) | Designated preferred name (PT) | NO | |
| RxCUI: 31830 | Nitrate reductase (reduced nicotinamide adenine dinucleotide) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31830 | Nitrate reductase (reduced nicotinamide adenine dinucleotide) | Full form of descriptor (FN) | NO | |
| RxCUI: 31831 | Nitrate reductase [NADPH] | Designated preferred name (PT) | NO | |
| RxCUI: 31831 | Nitrate reductase [NADPH] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31831 | Nitrate reductase [NADPH] | Full form of descriptor (FN) | NO | |
| RxCUI: 318338 | Mandelamine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 318340 | Aloe barbadensis extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 318340 | Aloe barbadensis extract | Designated preferred name (PT) | NO | |
| RxCUI: 318340 | Aloe barbadensis extract | Full form of descriptor (FN) | NO | |
| RxCUI: 318340 | Aloe barbadensis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 318341 | Cetuximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 318341 | Cetuximab | Designated preferred name (PT) | YES | |
| RxCUI: 318341 | Cetuximab | Full form of descriptor (FN) | YES | |
| RxCUI: 318341 | Cetuximab | Designated preferred name (PT) | YES | |
| RxCUI: 318341 | Cetuximab | Full form of descriptor (FN) | YES | |
| RxCUI: 31836 | Nitric-oxide reductase | Designated preferred name (PT) | NO | |
| RxCUI: 31836 | Nitric-oxide reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 31837 | Nitrilase | Designated preferred name (PT) | NO | |
| RxCUI: 31837 | Nitrilase | Full form of descriptor (FN) | NO | |
| RxCUI: 31838 | Nitrilase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31838 | Nitrilase | Designated preferred name (PT) | NO | |
| RxCUI: 31838 | Nitrilase | Full form of descriptor (FN) | NO | |
| RxCUI: 31840 | Nitrite reductase (reduced nicotinamide adenine dinucleotide phosphate) | Designated preferred name (PT) | NO | |
| RxCUI: 31840 | Nitrite reductase (reduced nicotinamide adenine dinucleotide phosphate) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31840 | Nitrite reductase (reduced nicotinamide adenine dinucleotide phosphate) | Full form of descriptor (FN) | NO | |
| RxCUI: 31862 | Adenosine diphosphate-ribosyl-[dinitrogen reductase] hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31862 | Adenosine diphosphate-ribosyl-[dinitrogen reductase] hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 31862 | Adenosine diphosphate-ribosyl-[dinitrogen reductase] hydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 31862 | Adenosine diphosphate-ribosyl-[dinitrogen reductase] hydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 31871 | Nitromide | Designated preferred name (PT) | NO | |
| RxCUI: 31871 | Nitromide | Full form of descriptor (FN) | NO | |
| RxCUI: 31875 | Nitroquinoline-N-oxide reductase | Designated preferred name (PT) | NO | |
| RxCUI: 31875 | Nitroquinoline-N-oxide reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 31898 | Nitrous-oxide reductase | Designated preferred name (PT) | NO | |
| RxCUI: 31898 | Nitrous-oxide reductase | Full form of descriptor (FN) | NO |